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Abstract
Activity-dependent modification of excitatory synaptic transmission is fundamental for
developmental plasticity of the neural circuits and experience-dependent plasticity. Synaptic
glutamatergic receptors including AMPA receptors and NMDA receptors (AMPARs and
NMDARs) are embedded in the highly organized protein network in the postsynaptic density.
Overwhelming data have shown that PSD-95-like membrane associated guanylate kinases (PSD-
MAGUKs), as a major family of scaffold proteins at glutamatergic synapses, regulate basal
synaptic AMPAR function and trafficking. It is now clear that PSD-MAGUKs have multifaceted
functions in terms of regulating synaptic transmission and plasticity. Here we discuss recent
advancements in understanding the roles of PSD-95 and other family members of PSD-MAGUKs
in synaptic plasticity, both as an anchoring protein for synaptic AMPARs and also as a signaling
scaffold for mediating the interaction of the signaling complex and NMDARs.
Introduction
PSD-95-like membrane associated guanylate kinases (PSD-MAGUKs) conform a major
family of multidomain scaffold proteins at glutamatergic synapses, including PSD-95
(SAP90), PSD-93 (Chapsyn-110), SAP102 and SAP97. They are multi-modular proteins
sharing the common domain structure composed of three PSD-95/Discs large/zona
occludens-1 (PDZ) domains, followed by a Src-homology-3 (SH3) domain and a
catalytically inactive guanylate kinase (GK) domain. They interact with a variety of
membrane proteins including ionotropic glutamate receptors, ion channels,
neuromodulartory receptors, cell-adhesion molecules. PSD-MAGUKs also interact with
intracellular proteins including other scaffold proteins, actin cytoskeleton components and
signaling proteins [1] [2] [3]. Among the family members, expression of PSD-95 and
PSD-93 has been shown to be dysregulated in neuropsychiatric patients [4], and loss of
function mutations in the SAP102 gene cause nonsyndromic X-linked mental retardation
[5]. Furthermore, within the array of interaction partners, several were identified in genetic
studies of neuropsychiatric and neurodevelopmental disorders, including neuroligins in
autism spectrum disorder [6], SAPAP3 in obsessive compulsive disorder [7], and its
interaction partner SHANK family proteins in ASD [8] [9], poising PSD-MAGUKs a central
role in orchestrating normal synaptic function at glutamatergic synapses. Here I focus on the
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recent studies exploring the possible roles of PSD-MAGUK in synaptic plasticity, and
discuss several prevalent hypotheses.
PSD-95 and synaptic plasticity
Among the four PSD-MAGUKs family members, PSD-95 is the most extensively studied in
the context of synaptic plasticity. It is highly enriched in the PSD [10] and has been
proposed to play an essential role for maintaining and regulating synaptic AMPAR function
[11**]. In vivo studies have shown that activity-dependent redistribution of PSD-95 in
visual cortex correlates with eye opening [12], and is thought to be involved in the control of
developmental plasticity [13]. PSD-mutant mice exhibit a variety of behavioral deficits
including learning deficit, drug addiction, suggesting its involvement in experience-
dependent plasticity [14*] [15]. I will first discuss the studies focusing on the role of
PSD-95 in regulating NMDAR-dependent synaptic plasticity. Then in the later part of the
review, I will discuss the functional diversity with other PSD-MAGUKs, and their possible
roles in other types of plasticity (summarized in Figure 1).
Given the central role of PSD-95 in scaffolding the ionotrophic glutamate receptors,
intracellular cytoskeleton components and signaling adaptors, two major hypotheses for how
PSD-95 regulates NMDAR-dependent synaptic plasticity are generated (1), as slot proteins
for AMPARs, PSD-95 acts as the target of the signaling during plasticity, in that changes in
the levels of PSD-95 directly influence the levels of synaptic AMPAR. (2), as a signaling
scaffold, that bring intracellular signaling complexes close to NMDAR channels. In other
words, PSD-95 bridges the calcium influx to the specific downstream signaling events.
Experimental work using genetically modified animals, overexpression, acute knockdown
and molecular replacement strategies has provided strong evidence supporting the role of
PSD-95 in controlling basal synaptic AMPAR levels [11]. Briefly, the levels of PSD-95 are
directly correlated with the size of AMPAR-mediated excitatory postsynaptic currents
(APMAR EPSCs). Overexpression of PSD-95 enhances and acute knockdown of PSD-95
decreases synaptic AMPAR EPSCs. While some studies in PSD-95 mutant mice showed
lack of effect on basal synaptic transmission [16] [14*], others showed AMPAR-mediated
response is decreased at certain developmental stages, presumably due to the changes of
other PSD-MAGUK during development [17] [18**]. In PSD-95 mutant mice, LTP was
greatly enhanced, whereas LTD is absent. Consistent with these results, acute knockdown of
PSD-95 blocked or decreased LTD [19**] [20]; whereas overexpression of PSD-95
occluded LTP and decreased the threshold for LTD induction [21] [22]. These data strongly
suggest the involvement of PSD-95 in synaptic plasticity; in particular, PSD-95 may be
indispensible for NMDAR-dependent LTD.
NMDAR-dependent LTD, slot hypothesis of PSD-95
It has been hypothesized that PSD-95 may act as a “slot” protein for synaptic AMPARs with
the concentration of PSD-95 at the synapse regulating synaptic AMPAR levels [23] [24]. In
this scenario, PSD-95 would be a target of the LTD signaling cascade and the reduction of
synaptic PSD-95 would lead to the loss of synaptic AMPARs. Data supporting this scenario
first came from studies of agonist-induced AMPAR endocytosis in dissociated neuron
culture. It has been reported that synaptic PSD-95 levels can be dynamically regulated via
palmitoylation and ubiquitination, and thereby influence synaptic AMPAR levels upon
agonist stimulation [24*,25*]. College et al (2003) showed that NMDA treatment of
dissociated cultures induced polyubiquitination of PSD-95 that directed PSD-95 to the
proteasomal degradation. The effect of ubiquitination of PSD-95 on synaptically induced
LTD has not been directly tested. Another study suggested that PSD-95 could be
palmitoylated at the N-terminal region [25*]. Palmitoylation is a reversible lipid
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modification process to the target protein, which will direct the protein to associate with the
cell membrane and thought to be involved in protein trafficking and signaling pathways
important for brain development and synaptic transmission [26]. PSD-95 in the PSD is
highly palmitoylated, and glutamate treatment of dissociated culture induces de-
palmitoylation of PSD-95 leading to the diffusion of PSD-95 out of the synapses,
accompanied by decreased synaptic AMPAR content [25*]. However, it has been shown
that membrane detachment of PSD-95 is not crucial for mediating synaptically induced
LTD, suggesting that this pathway may not be directly involved in the induction of LTD, but
likely contributing to other types of activity-dependent regulation of synaptic strength. A
recent study identified that a Rac1-JNK signaling pathway mediates phosphorylation of
S295 residue in PSD-95, which regulates synaptic content of PSD-95 [27]. S295
phosphorylation promotes synaptic accumulation of PSD-95 and influences synaptic
potentiation. NMDA treatment (culture model of LTD) decreases S295 phosphorylation,
whereas the chemical-induced LTP (chemLTP) stimulation increases S295 phosphorylation.
Moreover, overexpression of the mutant mimicking phosophorylation (S295D) blocks
AMPAR internalization and synaptically induced LTD. NMDA treatment decreases the
levels of S295 phosphorylation. S295A mutant that cannot be phosphorylated is less
effective in terms of synaptic accumulation of PSD-95 and enhancement of synaptic GluR1
content, and is permissive for LTD. These data suggest that dephosphorylation of S295 is
necessary for LTD induction and/or expression presumably by regulating synaptic PSD-95
levels [27*]. Thus at least three different types of activity-dependent post-translational
modification of PSD-95 can be used for regulating synaptic PSD-95 levels, hence synaptic
anchoring slots for AMPARs for the expression of LTD.
NMDAR-dependent LTD, signaling scaffold hypothesis of PSD-95
As a multimodular protein, PSD-MAGUKs interact with an array of intracellular proteins
that have been implicated in synaptic plasticity. Studies on PSD-95 mutant mice suggested
that PSD-95 is essential for mediating LTD. Using a molecular replacement strategy, studies
have shown that the effects of PSD-95 on regulating basal synaptic AMPAR function and
mediating LTD can be dissociated [19**]. The SH3-GK domain of PSD-95, which interacts
with AKAP79/150 is suggested to be critical for the expression of LTD at hippocampal
Shaffer-collateral CA1 synapses. Furthermore, the stability of PSD-95 is presumably crucial
for the LTD. PSD-95 is a relatively stable component in the PSD [28] [29*]. Mutants that
exhibit faster diffusion kinetics block LTD, and a double mutant that rescues the diffusion
kinetics rescues LTD as well [19**]. It has been shown that the interactions of AKAP79/150
with the downstream protein kinases and phosphatase are important for NMDAR-dependent
LTD [30–33]. PSD-95 is proposed to facilitate PP2B activation by positioning the associated
signaling complex close to the site of calcium influx through NMDARs, presumably via
AKAP79/150-PSD-95 interaction. The tri-partner interaction among PSD-95, AKAP79/150
and PP2B is likely highly dynamic and tightly regulated during LTD induction, but the
precise interaction dynamics during LTD remain unclear. Nevertheless, lack of PSD-95,
destabilizing mutants, and mutants disrupting the intracellular interaction with AKAP79/150
all disrupt LTD, presumably by de-coupling synaptic NMDARs from the LTD signaling
cascade [19**]. These evidences suggest a role of PSD-95 as a signaling scaffold for LTD.
Combining the two lines of evidences, it is conceivable to hypothesize that PSD-95 is
involved in LTD in two stages, first, as a signaling scaffold that mediates the dynamic
interactions involved in the signaling events during the LTD induction phase; second, as the
AMPARs anchoring protein in the PSD, is down-regulated via different mechanisms to
maintain the decreased synaptic AMPAR content at the expression phase of LTD. The
decrease of PSD-95 levels can thus also serve as a brake for the LTD signaling events.
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Data from PSD-95 mutant animals and overexpression studies suggest that PSD-95 is a
negative regulator of NMDAR-dependent LTP [14*] [21]. Acute knockdown studies
showed that the induction of synaptic LTP is not affected by the lack of PSD-95, whereas
spine growth (structural plasticity) is impaired [20] [29*], suggesting the different
contribution of PSD-95 in regulating structural and functional LTP. It has been shown that
S295 of PSD-95 can be dephosphorylated with the chemLTP protocol [27*], but whether
this process contributes to LTP induction and expression has not been explored. Another
study has shown that the diffusion dynamics of PSD-95 can be increased by CaMKII
activity during the LTP induction phase likely through phosphorylation of Serine residue at
position 73 (S73) [29*]. The phosphomimetic mutant (S73D) destabilizes the PSD and
inhibits activity-dependent spine growth and synaptic potentiation. This line of evidence
suggests that the stability of PSD-95 during the initial phase of LTP is important for the
spine growth and expression of LTP, and the phosphorylation of PSD-95 at S73 is likely a
limiting factor for structural and functional postsynaptic potentiation. It is worthwhile to
notice that S73A (non-phosphorylatable mutant) and S73D mutants have similar effect on
enhancing synaptic AMPAR levels to that of wild-type of PSD-95, suggesting that the effect
on basal transmission and the involvement of PSD-95 in regulating structural and functional
plasticity are in principle, separable. The degrees of LTP in both wild-type and S73A
(stable) overexpression cases are significantly less compared to GFP control, in line with the
evidence from mutant animals that PSD-95 a negative regulator of functional LTP, whereas
S73D (less stable) overexpression completely blocks functional LTP. These evidences
suggest that the dynamics of PSD-95 has to be temporally tightly regulated, to establish the
sequential events for the expression of LTP.
Plasticity of NMDAR
Recent studies suggest that PSD-95 is involved in muscarinic acetylcholine receptors
(mAChRs)-induced LTD of NMDAR mediated synaptic transmission [34]. Knocking down
PSD-95 and replacement with PSD-95 mutants lacking the SH3 domain blocked mAchR
agonist-induced LTD of NMDAR EPSCs due to the disruption of interaction with
hippocalcin. This effect can also be dissociated from the effects of PSD-95 on AMPAR and
NMDAR EPSCs. Thus, several lines of evidence showed that effects of PSD-95 on basal
synaptic transmission and several forms of synaptic plasticity can be dissociated,
presumably because different domains and interaction sites are differentially involved in
these processes.
Homeostatic plasticity
Homeostatic plasticity acts to stabilize the neuronal activity upon perturbations [35]. In the
dissociated neuronal culture system, when synaptic activity is chronically blocked with
TTX, synaptic AMPAR responses are elevated to compensate the lack of activity; whereas
when neuronal activity is chronically elevated with GABAR blocker bicuculline, synaptic
AMPAR responses are decreased. This experimental observation, named as synaptic scaling,
has been used as a model for homeostatic plasticity. The first indication of the involvement
of PSD-95 in homeostatic plasticity came from the study from dissociated cortical culture
work, in a study demonstrating that levels of PSD-95 are dynamically regulated with chronic
activity modulation [36]. Furthermore, the phosphorylation of S295 in PSD-95 can be
regulated by chronic activity manipulation [27]. With chronic treatment of TTX, which
scales up synaptic AMPAR responses, S295 phosphorylation is upregulated, presumably
promoting synaptic localization of PSD-95. In contrary, chronic treatment of bicuculline
causes opposite effects. Synaptic translocation of PSD-95 can be regulated by brain-derived
neurotrophic factor (BDNF) that has been implicated in LTP and synaptic scaling [37].
These correlative observations suggest that regulation of PSD-95 may contribute to synaptic
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scaling. However, direct test on whether changes in PSD-95 levels and phosphorylation
states of PSD-95 mediate homeostatic changes of synaptic AMPAR responses is lacking.
Other PSD-MAGUKs and plasticity
Evidence of the involvement of PSD-MAGUKs in synaptic plasticity first came from studies
on genetically mutated animals. Among four family members, genetic deletion of PSD-95,
PSD-93 and SAP102 have all shown deficit in a variety of hebbian type synaptic plasticity
[14] [38*] [18]. SAP97-null animals are embryonic lethal, and studies on conditional
knockout have not shown deficit in NMDAR-dependent LTP paradigm [39]. Table 1
compares the outcome in plasticity from PSD-MAGUK mutant mice. In this section, I will
review studies on the involvement of PSD-93, SAP102, and SAP97 in synaptic plasticity in
comparison to PSD-95, and discuss the possible functional diversities among different PSD-
MAGUKs.
PSD-93
Previous studies suggest that the role of PSD-95 and PSD-93 in regulating basal synaptic
AMPAR function is overlapping [11]. The expression profiles throughout development are
similar as well. In rodents, PSD-95 and PSD-93 express at low level early during
development, and start to increase the expression from postnatal 10 days until reaches high
levels in the adulthood (6 months) [40]. Although the phenotypes on basal transmission by
regulating either PSD-95 or PSD-93 levels are similar, the outcome on synaptic plasticity is
dramatically different. While PSD-95 knockout animals exhibit an enhancement of LTP and
deficit in LTD, PSD-93 animals, however, showed a decrease of LTP in several paradigms
including spike timing dependent plasticity [18]. It is unknown what causes the opposite
effects on synaptic plasticity mediated by PSD-95 and PSD-93. Combined with previous
studies on PSD-95, it is possible that PSD-95 and PSD-93 scaffold different protein
complexes; therefore influence the outcome of synaptic plasticity differently. It has been
hypothesized that PSD-95 and PSD-93 may be localized to different synapses, raising the
possibility that synapses from the same cell may exhibit different plasticity properties given
which protein is predominantly expressed [11,18]. There are six splice isoforms of PSD-93
that differ in the N-terminal region, much more diverse compared to other PSD-MAGUKs
[41]. The cellular distribution, and the how these different splice isoforms regulate basal
synaptic transmission and plasticity remain unknown. Understanding the functional diversity
of these splice isoforms will provide important information in the diversity of glutamatergic
synaptic transmission.
SAP97
Predominant SAP97 isoform contains an L27 domain in the N-terminal region (β-isoform)
different from the predominant PSD-95 isoform that has a palmitoylation signal in the N-
terminal region (α-isoform) [42,43*]. Unlike PSD-95, which interacts with AMPARs
through direct binding to the transmembrane AMPAR regulatory proteins (TARPs) [23,44],
SAP97 binds directly the AMPAR subunit GluR1 [45,46]. Studies on basal transmission
showed that overexpression of SAP97 has little effect on synaptic AMPAR and NMDAR
current, while others have shown a slight increase in both [23,42,43]. When expressed in the
absence of endogenous PSD-95, however, it can rescue the decrease of AMPAR EPSCs
caused by the loss of PSD-95. Interestingly, this rescue depends on NMDAR and CaMK
activity, suggesting the involvement of SAP97 in the LTP signaling pathway[43*]. Studies
have shown that acute knockdown of SAP97 causes deficit in LTP [42]. However, when
tested in a knockout mouse line, LTP appears to be normal [39]. This apparent controversy
suggested that SAP97 may play a regulatory role in LTP, and is not an essential component
in LTP pathway. Alternatively, the absence of SAP97 through development (in the Nestin-
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cre crossed flx-SAP97 mouse line), other proteins can compensate the loss of SAP97 in
LTP.
SAP102
SAP102 starts to express early during development, and its expression stays stable
throughout the adulthood [40]. In comparison, the expression of PSD-95 starts from
postnatal day 10 and increases throughout development until adulthood. Comparing to
PSD-95, SAP102 has an unstructured N-terminal region. In mature neurons, SAP102 is
highly mobile compared to PSD-95 [47]. During development, PSD-95 becomes enriched in
the PSD [40]. Consistent with this observation, manipulating SAP102 in relatively mature
neurons has no effect on AMPAR EPSCs, whereas manipulating SAP102 early in the
development decreases AMPAR EPSCs significantly [48]. The developmental profile
change between SAP102 and PSD-95 also coincides with the time course of NR2A-
containing NMDAR enrichment at the synapse, replacing NR2B-containg NMDARs that
express predominantly during early development [40]. Changes in synaptic NR2A vs NR2B
containing NMDARs have been proposed to be a mechanism for modulate plasticity [49].
Original biochemical data suggests that SAP102 preferentially interacts with NR2A
containing NMDARs, whereas PSD-95 preferentially interacts with NR2B containing
NMDARs [40]. This idea is further supported by functional analysis where PSD-95 mutant
animals have slower NMDAR mediated synaptic current kinetics (i.e. NR2B containing
prone) [17], whereas overexpression of PSD-95 accelerates NMDAR kinetics (NR2A prone)
[48]. However, recent studies have shown that PSD-95, PSD-93 and SAP102 share similar
affinity to NR2A vs NR2B subunits in mature animals [50]. It is likely that this interaction
between PSD-MAGUKs and different NR2 subunits is regulated during development, and at
different developmental stages, they exhibit different interaction affinity.
Studies in SAP102 knockout animals showed that lack of SAP102 has no effect on basal
transmission and presynaptic function, but causes the enhancement both in high frequency
induced LTP and spike timing dependent LTP [38*]. This phenotype is similar to that of
PSD-95 mutant mice. Interestingly, in both of the deletion mutant lines, the counter part of
the pair is upregulated, suggesting a compensatory mechanism among PSD-MAGUKs,
possibly for the maintenance of basal synaptic transmission. However, further studies
suggest that the signaling pathways responsible for enhanced LTP are different in these two
mutant mouse lines. In SAP102 null mice, inhibiting the ERK signaling pathway can block
the enhancement of LTP, whereas the enhancement of LTP in PSD-95 mutant mice is ERK-
pathway independent [38*,51]. These results suggest that although PSD-95 and SAP102
possibly share similar effect of negatively regulating LTP, the detailed mechanisms may be
different. Both of the genetically modified mouse lines are constitutive knockout throughout
the whole brain and in both excitatory and inhibitory neurons, how lack of PSD-95 and
SAP102 affects the abnormality in synaptic plasticity during development, and in inhibitory
neurons is unknown. Further studies with more temporal- and cell-type specific
manipulations should provide more information in how SAP102 is involved in synaptic
plasticity.
Conclusion
The role of PSD-95 in regulating synaptic AMPAR functions has been established with
overwhelming evidence. In this review, I summarized the recent studies supporting that
PSD-95 not only forms structural scaffold for anchoring AMPARs at the PSD, but also
serves as the signaling scaffold to bridge the intracellular signaling complex the NMDARs.
The effects of PSD-95 on regulating basal synaptic AMPAR function and plasticity can be
separated. Furthermore, the dynamics of PSD-95 is highly regulated during synaptic
plasticity, and this likely contributes to the expression and termination of synaptic plasticity.
Xu Page 6













Emerging data from knockout animals and molecular manipulations suggest that PSD-
MAGUKs are functionally diverse in terms of regulating synaptic plasticity. Future studies
will be forthcoming to gain some insight on how this diversity is achieved, and to what
extent PSD-MAGUKs contribute to orchestrating the signaling cascades for the various
types of synaptic plasticity at glutamatergic synapses.
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Schematic diagram of sites in PSD-95 involved in synaptic plasticity. PSD-95 is involved in
synaptic plasticity in several scenarios. Palmitoylation, ubiquitination and phosphorylation
of S295 have been proposed to be involved in regulating activity-dependent synaptic cycling
of PSD-95 that influence the anchoring of synaptic AMPARs at the synapse during LTD
[24, 25, 27]. S295 is also thought to be involved in LTP and homeostatic plasticity. The
functions of PSD-95 in regulating basal synaptic transmission and plasticity are dissociable.
Three lines of evidence show that mutants that do not have impact on the function of
PSD-95 in regulating basal synaptic transmission can influence synaptic plasticity.
Phosphorylation of S73 by CaMKII is involved in regulating the dynamics of PSD-95
during LTP, and thought to be important for structural and functional plasticity [29]. SH3
domain mediated interaction with hippocalcin is important in mediating mAchR-dependent
LTD of NMDARs [34]. The interaction through SH3-GK domain, presumably with
AKAP150/79 is thought to be important for mediating LTD [19]. Therefore, PSD-95 has
multifaceted effects on synaptic transmission and plasticity.
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Phenotypes of synaptic function and synaptic plasticity of PSD-MAGUK mutant mice
PSD-95 [14,18] PSD-93 [18] SAP97 [39] SAP102 [38]
basal transmission decreased/not affected not affected not affected not affected
Paired pulse ratio enhanced enhanced n.a. normal
High frequency stim-LTP enhanced slightly decreased n.a. enhanced
LTP saturation level enhanced n.a. n.a. n.a.
Theta burst stim-LTP enhanced impaired n.a. n.a.
5Hz-LTP (threshold) enhanced n.a. n.a. enhanced
pairing LTP enhanced n.a. not affected n.a.
Spike-timing-dependent-LTP 1AP pair 10Hz enhanced normal n.a. enhanced
Spike-timing-dependent-LTP burst pair 10Hz slightly enhanced impaired n.a. normal
Low frequency stim-LTD deficient normal n.a. n.a.
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